Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 372.40
-2.05 (-0.55%)
At close: Aug 21, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 98.21 billion as of August 21, 2026. Its market cap has increased by 83.60% in one year.
Market Cap
98.21B
Enterprise Value
93.20B
Revenue
88.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
372.40
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 98.21B, an increase of 5,994.30%. That is a compound annual growth rate of 18.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 98.21B | 158.76% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.90B |
| Shilpa Medicare | 158.44B |
| IOL Chemicals and Pharmaceuticals | 46.86B |
| Gujarat Themis Biosyn | 40.57B |
| Sai Parenteral's | 23.87B |
| NGL Fine-Chem | 18.68B |
| Bajaj HealthCare | 10.75B |
| Anlon Healthcare | 7.78B |